We joined World Patient Safety Day on September 17th!
17th September is celebrated around the world as World Patient Safety Day. Organised by the World Health Organisation, the day is used to advocate for...
EFA Patients highlights from 2020 online ERS Congress
Although this year it was particularly difficult to choose among the variety and intense 4 full days programme at the 2020 European Respiratory Society...
First CURE project findings published!
The CURE project is now in its third year of research, entering a period of evidence production. On August 4th, the first publication steaming from the...
ImmUniverse: Improving diagnostic and therapeutic options for atopic eczema patients
Through ImmUniverse, EFA is involved in research aiming at improving diagnostic and therapeutic options for patients living with immune-mediated inflammatory...
3TR: young and senior asthma and COPD patients involved in biomarker research
3TR is a high-end research project that aims at improving treatment available for asthma and COPD. Funded by the Innovative Medicine Initiative (IMI),...
EFA response to the review of the EU Regulation on Fluorinated Greenhouse Gases
In September EFA participated in the Inception Impact Assessment consultation launched by the European Commission Directorate General for Climate Action...
The psychological burden of atopic eczema will be discussed at the EADV Congress
The 2020 EADV Congress will take place from the 29-31 of October, as a global virtual event. Do not miss EFA’s session on the socio-psychological burden...
We showed how much we #CareforAtopicEczema
We are stronger together! On 14th September we celebrated World Atopic Eczema Day. The day connected patients, caregivers, healthcare professionals, and...
EFA launches #ShowLeadership campaign
Living with allergies and airways diseases has become a daily burden for over 200 million people in Europe. The drastic increase of people living with...
Which priorities for a European policy on multimorbidity?
On the 27th of October, EFA EU Policy and Membership Officer Jelena Malinina attended the conference on multimorbidity organised by the European Commission...
Unsafe prescribing increases risk of life threatening asthma attacks
Last year’s National Review of Asthma Deaths highlighted prescribing errors in nearly half of asthma deaths in primary care (47%) in the United Kingdom....
e-Cigarettes policy guide
As the Tobacco Products Directive will be soon implemented at national level, EFA and ENSP we have developed a guide for EU Member States with recommendations...